Actnova, a Daejon, South Korea-based AI SaaS solution developer known for the 'Actverse' animal behavior testing platform, has secured KRW 3.3 billion ($3M) in pre-series A funding.  

SaaS Investors 

The round was led by Hana Ventures, with participation from A Ventures and Fast Ventures.  

Founded in 2018, Hana Ventures is the corporate venture capital arm of Hana Financial Group based in Seoul, South Korea. The firm prefers to invest in seed-stage, early-stage, and later-stage companies operating in consumer products, consumer services, financial services, healthcare, information technology, and life sciences sectors.  

Actnova Use of Funds 

The company will use the funding to support global expansion, product launches, and collaborations with research institutes and pharmaceutical companies.  

About Actnova 

Actnova is a developer of artificial intelligence-based technology designed for behavior analysis and visualization. The company platform automates the behavioral testing process in clinical and non-clinical fields with artificial intelligence image processing technology, enabling clients to observe and evaluate experimental animals and patients in the process of testing stability and efficacy. Actnova utilizes AI and web platform technologies to analyze behavioral symptoms in animal models, primarily focusing on the development of treatments for brain disorders like dementia and Parkinson's disease. 

Funding Details    

Company: ACTNOVA, Inc.  

Raised: $3.0M          

Round: Pre-Series A   

Funding Month: February 2024           

Lead Investors: Hana Ventures  

Additional Investors: A Ventures and Fast Ventures  

Company Website: http://www.actnova.io/   

Software Category: AI Vision-based Behavior Test Platform  

Source: https://wowtale.net/2024/02/07/71411/